Go to navigation Go to content
Toll-Free: (888) 606-5297
Phone: (859) 578-4444
Schachter, Hendy & Johnson, Attorneys At Law

Health Analyst Says AndroGel Increases Cardiovascular Risks

Comments (0)

According to Health Analyst, Bill Marder, a recent study published in PLOS ONE found that our modern pharmaceutical solutions for low testosterone are posing significant risks to the men taking testosterone drugs, like AndroGel.

The study, by William Finkle and colleagues, examined the frequency of adverse side effects stemming from testosterone therapy. It found an increased risk of heart attack in men younger than 65 with a history of heart disease and in older men even without a history of heart disease. The study results have garnered a lot of interest and even prompted the Food and Drug Administration (FDA) to review the safety of the therapy. The results and their ripple effects are getting a lot of attention in the press and for a number of good reasons.

First, testosterone therapy has been a rapidly growing phenomenon. Some of the growth is related to our aging population, but their manufacturers have also promoted these hormone supplements as a cure for low testosterone or
“low T” (code for diminished sex drive) — and that has been controversial. Sexual references tend to generate a fair amount of press, all other things equal.

Second, any drug marketed with direct-to-consumer advertising can expect more press because it is familiar to the public and the advertising itself generates controversy. Patients are more likely to request an advertised drug from their physician and that can influence prescribing decisions.

Finally, and perhaps most importantly, this study is getting a lot of attention because it is well done. This is an observational study that examined a large population — 55,593 men. All of these men had been prescribed testosterone treatments and 48,539 of them were younger than 65 years old.

The study was executed with great care and its results reflect the power of observational studies to advance our understanding of complex events, especially those that are rare. The authors analyzed medical and drug claims from our Truven Health MarketScan® Research databases, meaning they had access to the most robust Big Data healthcare claims source in the industry. It has been referenced in hundreds of peer-reviewed studies and this one is an interesting new addition to the literature.

Schachter, Hendy & Johnson, P.S.C. represents many men who had a stroke, pulmonary embolism, blood clot or heart attack as a result of taking testosterone replacement drugs, like AndroGel. If you or a loved one have suffered a stroke, pulmonary embolism, blood clot or heart attack while taking AndroGel or another testosterone drug, please call our experienced AndroGel attorneys at (888) 606-5297 for a free consutlation about your potential AndroGel lawsuit.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.

Live Chat